HAVCR2 and neoplasm: Notably, the majority of tumor-infiltrating Tregs express TIM-3 (55, 66), and antibody-mediated inhibition of TIM-3 in murine models has been shown to suppress tumor growth by reducing Treg effector molecule production (65).